Jitai Technology (Beijing) Co., Ltd. plans to list on the Main Board of the Hong Kong Stock Exchange on May 13, 2026, under the stock code "07666". The company intends to issue 201 million H shares at an issue price of HK$10.50 per share, with an expected fundraising scale exceeding HK$2.1 billion (approximately US$269 million). Jefferies, Deutsche Bank, and CITIC Securities are serving as the joint sponsors. The IPO features a strong lineup of cornerstone investors, including 18 top-tier institutions such as BlackRock, UBS AM Singapore, and Hillhouse, with cumulative subscriptions totaling US$148 million. Founded in 2020, Jitai Technology is a national-level high-tech enterprise specializing in AI-driven drug delivery and formulation development. Its self-developed NanoForge, the world's first AI nano-delivery platform, enables multi-organ targeted delivery and has established a research and development pipeline covering various indications.